Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study

Arielle Mendel,Marvin J Fritzler,Yvan St-Pierre,Joyce Rauch,Sasha Bernatsky,Évelyne Vinet

Research and Practice in Thrombosis and Haemostasis（2023）

引用 1|浏览17

暂无评分

摘要

•Antiphospholipid antibodies (aPLs) are observed in patients with COVID-19; however, their significance is unclear.•We studied people tested for SARS-CoV-2 (March-July 2020) at an academic hospital.•More people with COVID-19 had aPLs compared with those who tested negative.•Some aPLs were associated with kidney injury, requiring a ventilator, and blood clots.

查看译文

关键词

acute kidney injury,adult,antibodies,antiphospholipid,COVID-19,intensive care units,prospective studies,SARS-CoV-2,thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要